Titan Biotech Balance Sheet Annual

Trade

BSE: 524717 | NSE: - | ISIN: INE150C01011 | Sector: Biotechnology & Drugs

789.70 +24.20 (3.16%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	2.84	4.86	6.81	5.45
Cashand Short Term Investments	2.84	4.86	6.81	5.45
Accounts Receivable- Trade Net	18.66	21.01	16.36	18.10
Total Receivables Net	18.71	22.06	16.63	18.96
Total Inventory	45.57	36.56	34.68	34.20
Other Current Assets Total	5.05	4.32	5.63	0.09
Total Current Assets	72.17	68.31	63.76	58.83
Property/ Plant/ Equipment Total- Net	54.47	49.10	38.51	33.79
Intangibles Net	0.10	0.09	0.10	0.09
Long Term Investments	29.84	15.67	4.19	-
Total Assets	156.58	134.52	108.09	100.72
Accounts Payable	3.37	5.55	4.16	3.71
Accrued Expenses	0.56	0.33	0.29	0.17
Notes Payable/ Short Term Debt	6.72	5.53	4.72	8.29
Current Portof LT Debt/ Capital Leases	0.44	1.55	2.02	1.45
Other Currentliabilities Total	8.05	7.39	5.76	5.66
Total Current Liabilities	19.13	20.35	16.95	19.28
Long Term Debt	0.45	-	0.89	4.65
Capital Lease Obligations	0.69	1.43	1.30	1.61
Total Long Term Debt	1.15	1.43	2.19	6.25
Total Debt	8.30	8.51	8.93	15.99
Deferred Income Tax	1.37	1.21	1.28	1.39
Minority Interest	0.00	-	-	3.72
Other Liabilities Total	1.48	1.62	1.43	1.32
Total Liabilities	23.13	24.60	21.85	31.96
Common Stock Total	8.26	8.26	8.26	8.26
Retained Earnings( Accumulated Deficit)	125.19	92.82	69.22	60.49
Total Equity	133.45	109.91	86.24	68.76
Total Liabilities Shareholders' Equity	156.58	134.52	108.09	100.72
Total Common Shares Outstanding	0.83	0.83	0.83	0.83
Tangible Book Valueper Share Common Eq	161.38	132.90	104.24	83.09
Prepaid Expenses	-	0.50	0.00	0.12
Property/ Plant/ Equipment Total- Gross	-	65.27	52.12	45.34
Accumulated Depreciation Total	-	-16.17	-13.61	-11.55
Note Receivable- Long Term	-	0.39	0.48	6.27
Other Long Term Assets Total	-	0.96	1.04	1.74
Additional Paid- In Capital	-	8.68	8.68	-
Other Equity Total	-	0.15	0.09	0.00